Who founded Predxbio?

Predxbio was founded by S. Chakra Chennubhotla, D. Lansing Taylor, Michael J. Becich, Jeffrey L. Fine.

Who are Predxbio's investors?

Predxbio's investors include Central Texas Angel Network, Emerging Ventures, Keiretsu Forum, Newlin Investment Company LLC, NW Angel.

Predxbio

5 known investors

Find your way into Predxbio

222 people in our graph share verified history with the Predxbio team — schools, employers, funds. One of them is your warm intro.

Javier Solterounlockedknows Bruce · together at Carnegie Mellon University (overlapped)

×4knows the team · via Carnegie Mellon University

knows the team · via Harvard University

×6knows the team · via University at Albany

PredxBio develops tissue analysis software that uses spatial multi-omics data to identify biomarkers and inform drug development decisions. The platform helps pharmaceutical and biotech companies move from exploratory tissue analysis to clinical development with explainable insights about cell states, microenvironments, and therapeutic response patterns.

AI & Machine Learning Biotech Medical Devices

Founders & leadership

S. Chakra ChennubhotlainChief Executive Officer & Co-founder

D. Lansing Taylor inCo-founder, Scientific & Business AdvisorDr. Taylor has held academic positions at Harvard, Carnegie Mellon University, and the University of Pittsburgh, and has founded or led multiple biotechnology companies including Cellomics, Cellumen, Cernostics, and Biosystics. His expertise spans quantitative systems pharmacology, patient-derived cellular models, and spatial omics approaches applied to drug discovery in liver disease and oncology.

Michael J. BecichinCo-founder, Scientific Advisor

Jeffrey L. FineinCo-founder, Scientific Advisor

B. Dusty MajumdarinChief Executive Officer

Joe CamarattainSr. VP Business Development

Bruce inVP Software Engineering

Investors · 5

Central Texas Angel NetworkAustin

Emerging VenturesLos Angeles · $100K – $500K

Keiretsu ForumSan Francisco · $250K – $2M

Newlin Investment Company LLCPittsburgh · $100K – $3M

NW AngelSeattle

Frequently asked questions

What does Predxbio do?: PredxBio develops tissue analysis software that uses spatial multi-omics data to identify biomarkers and inform drug development decisions. The platform helps pharmaceutical and biotech companies move from exploratory tissue analysis to clinical development with explainable insights about cell states, microenvironments, and therapeutic response patterns.
Who founded Predxbio?: Predxbio was founded by S. Chakra Chennubhotla, D. Lansing Taylor, Michael J. Becich, Jeffrey L. Fine.
Who are Predxbio's investors?: Predxbio's investors include Central Texas Angel Network, Emerging Ventures, Keiretsu Forum, Newlin Investment Company LLC, NW Angel.